New chemotherapeutic agents in the treatment of non-small cell lung cancer: The Australian experience

Chest

Volumn 113, Issue 1 SUPPL., 1998, Pages 24S-27S

  Boyer, Michael J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CIMETIDINE; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; DOCETAXEL; ETOPOSIDE; GEMCITABINE; PACLITAXEL;

ARTHRALGIA; AUSTRALIA; BONE MARROW SUPPRESSION; CANCER RESEARCH; CLINICAL TRIAL; DRUG INDUCED DISEASE; DRUG RESEARCH; DRUG RESPONSE; GASTROINTESTINAL SYMPTOM; HEARING LOSS; HEART ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; LUNG NON SMALL CELL CANCER; MYALGIA; NEUROPATHY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW;

EID: 0031975617     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Coates M, Day P, McCredie M, et al. Cancer in New South Wales: incidence and mortality 1992. Sydney: NSW Cancer Council, 1995
2. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994; 86:673-80
3. Rossell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994; 330:153-58
4. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990; 323:940-45
5. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311:899-909
6. Millward MJ, Bishop JF, Friedlander M, et al. Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small cell lung cancer. J Clin Oncol 1996; 14:142-48
7. Murphy WK, Fossella FV, Winn RJ. Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 1993; 85:384-88
8. Chang AY, Kim K, Glick J. Phase II study of Taxol, merbarone and piroxantrone in stage IV non-small cell lung cancer: the Eastern Cooperative Oncology Group results. J Natl Cancer Inst 1993; 85:388-94
9. Boyer MJ, Olver IN, Millward MJ, et al. Phase I study of two schedule's of Taxol and oral etoposide in patients with small-cell or non-small cell lung cancer [abstract]. Proc Am Soc Clin Oncol 1996; 15:390
10. Zalcberg JR, Bishop JF, Webster LK, et al. A phase I trial of the combination of Taxotere (docetaxel) and cisplatin in patients with advanced non-small cell lung cancer [abstract]. Ann Oncol 1994; 5:773
11. Zalcberg JR, Bishop JF, Millward MJ, et al. Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer [abstract]. Presented at the Proceedings of the European Conference on Clincal Oncology, Paris, France, November 1995
12. Cole JT, Gralla RJ, Marques CB, et al. Phase I-II study of cisplatin+docetaxel (Taxotere) in non-small cell lung cancer [abstract]. Proc Am Soc Clin Oncol 1995; 14:357
13. Le Chevalier T, Belli L, Monnier A, et al. Phase II study of docetaxel (Taxotere) and cisplatin in advanced non-small cell lung cancer [abstract]. Proc Am Soc Clin Oncol 1995; 14:350
14. Begbie SD, Hui R, Levi JA, et al. Initial experience with gemcitabine for non-small cell lung cancer in Australia [abstract]. Proc Am Soc Clin Oncol 1995; 14:378